CHINA 'Falcon' air-inflated testing lab built for massive nucleic acid tests in Lanzhou, Gansu

CHINA

'Falcon' air-inflated testing lab built for massive nucleic acid tests in Lanzhou, Gansu

China.org.cn

11:21, October 25, 2021

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city. (Photos by Chen Bin/ Xinhua)

Aerial photo shows the "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker woks at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

Medical workers work at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

Medical workers are seen at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

Medical workers work at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

Medical workers transfer collected samples for nucleic acid test outside a "Falcon" air-inflated testing lab in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker works at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

A medical worker paints on the protective suit of her colleague at a "Falcon" air-inflated testing lab for COVID-19 nucleic acid testing in Lanzhou, northwest China's Gansu Province, Oct. 24, 2021. A set of "Falcon" air-inflated testing lab has been built in Lanzhou for massive nucleic acid tests. The lab is capable of screening up to 800,000 people every day using the ten-in-one mixed testing approach, which greatly improved the testing capabilitiy after the recent resurgence of COVID-19 cases in the city.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue